| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Editorial; Introductory Journal Article
- Language: English
- [Patient] 2021 May; Vol. 14 (3), pp. 303-307. <i>Date of Electronic Publication: </i>2021 Apr 22.
- MeSH Terms: Choice Behavior* ; Health Policy* ; Public Opinion* ; COVID-19 / *epidemiology ; Australia / epidemiology ; COVID-19 Vaccines / administration & dosage ; Communicable Disease Control / organization & administration ; Decision Support Techniques ; Health Care Rationing / organization & administration ; Humans ; Pandemics ; Quality-Adjusted Life Years ; SARS-CoV-2 ; Severity of Illness Index ; Singapore / epidemiology ; Vaccination Coverage
- References: Ozdemir S, Tan SNG, Chaudhry I, et al. Public preferences for government response policies on outbreak control. Patient. 2021. https://doi.org/10.1007/s40271-020-00494-9 . (PMID: 10.1007/s40271-020-00494-9338400788035860) ; Manipis K, Street D, Cronin P, et al. Exploring the trade-off between economic and health outcomes during a pandemic: a discrete choice experiment of lockdown policies in Australia. Patient. 2021. https://doi.org/10.1007/s40271-021-00503-5 . (PMID: 10.1007/s40271-021-00503-5336940767946575) ; Degeling C, et al. Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment. BMJ Open. 2020;10(11):e041592. (PMID: 10.1136/bmjopen-2020-041592) ; Jonker M, et al. COVID-19 contact tracing apps: predicted uptake in the Netherlands based on a discrete choice experiment. JMIR Mhealth Uhealth. 2020;8(10):e20741. (PMID: 10.2196/20741) ; Cohen IG, Gostin LO, Weitzner DJ. Digital smartphone tracking for COVID-19: public health and civil liberties in tension. JAMA. 2020;323(23):2371–2. (PMID: 10.1001/jama.2020.8570) ; Sabat I, et al. United but divided: policy responses and people’s perceptions in the EU during the COVID-19 outbreak. Health Policy. 2020;124(9):909–18. (PMID: 10.1016/j.healthpol.2020.06.009) ; Reed S, Gonzalez JM, Johnson FR. Willingness to accept trade-offs among COVID-19 cases, social-distancing restrictions, and economic impact: a nationwide US study. Value Health. 2020;23(11):1438–43. (PMID: 10.1016/j.jval.2020.07.003) ; Emanuel EJ, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;382(21):2049–55. (PMID: 10.1056/NEJMsb2005114) ; Maves RC, et al. Triage of scarce critical care resources in COVID-19 an implementation guide for regional allocation: an expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest. 2020;158(1):212–25. (PMID: 10.1016/j.chest.2020.03.063) ; Norman R, Robinson S, Dickinson H, et al. Public preferences for allocating ventilators in an intensive care unit: a discrete choice experiment. Patient. 2021. https://doi.org/10.1007/s40271-021-00498-z . (PMID: 10.1007/s40271-021-00498-z336601637929628) ; Han SA, Koch VG. Clinical and ethical considerations in allocation of ventilators in an influenza pandemic or other public health disaster: a comparison of the 2007 and 2015 New York State Ventilator Allocation Guidelines. Disaster Med Public Health Prep. 2020;14(6):e35–44. https://doi.org/10.1017/dmp.2020.232 . (PMID: 10.1017/dmp.2020.23232660660) ; Piscitello GM, et al. Variation in ventilator allocation guidelines by US state during the coronavirus disease 2019 pandemic: a systematic review. JAMA Netw Open. 2020;3(6):e2012606. (PMID: 10.1001/jamanetworkopen.2020.12606) ; Reynolds JM, Guidry-Grimes L, Savin K. Against personal ventilator reallocation. Camb Q Healthc Ethics. 2021;30(2):272–84. https://doi.org/10.1017/S0963180120000833 . (PMID: 10.1017/S096318012000083333004101) ; Yahya AS, Khawaja S. Medical ethics and ventilator allocation during the COVID-19 pandemic. Prim Care Companion CNS Disord. 2020;22(4):20com02687. https://doi.org/10.4088/PCC.20com02687. (PMID: 10.4088/PCC.20com0268732678525) ; Bauer J, et al. Access to intensive care in 14 European countries: a spatial analysis of intensive care need and capacity in the light of COVID-19. Intensive Care Med. 2020;46(11):2026–34. (PMID: 10.1007/s00134-020-06229-6) ; Shoukat A, et al. Projecting demand for critical care beds during COVID-19 outbreaks in Canada. CMAJ. 2020;192(19):E489-e496. (PMID: 10.1503/cmaj.200457) ; Gijsbers M, Keizer IE, Schouten SE, et al. Public preferences in priority setting when admitting patients to the ICU during the COVID-19 crisis: a pilot study. Patient. 2021. https://doi.org/10.1007/s40271-021-00504-4 . (PMID: 10.1007/s40271-021-00504-4337489307982314) ; Grover S, McClelland A, Furnham A. Preferences for scarce medical resource allocation: differences between experts and the general public and implications for the COVID-19 pandemic. Br J Health Psychol. 2020;25(4):889–901. (PMID: 10.1111/bjhp.12439) ; Ubel PA, et al. Allocation of transplantable organs: do people want to punish patients for causing their illness? Liver Transpl. 2001;7(7):600–7. (PMID: 10.1053/jlts.2001.25361) ; Burki TK. Herd immunity for COVID-19. Lancet Respir Med. 2021;9(2):135–6. https://doi.org/10.1016/S2213-2600(20)30555-5 . (PMID: 10.1016/S2213-2600(20)30555-533245861) ; Clemente-Suárez VJ, Hormeño-Holgado A, Jiménez M, Benitez-Agudelo JC, Navarro-Jiménez E, Perez-Palencia N, Maestre-Serrano R, Laborde-Cárdenas CC, Tornero-Aguilera JF. Dynamics of population immunity due to the herd effect in the COVID-19 pandemic. Vaccines (Basel). 2020;8(2):236. https://doi.org/10.3390/vaccines8020236 . (PMID: 10.3390/vaccines8020236) ; Frederiksen LSF, et al. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817. (PMID: 10.3389/fimmu.2020.01817) ; Kwok KO, et al. Herd immunity—estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020;80(6):e32–3. (PMID: 10.1016/j.jinf.2020.03.027) ; Phelan AL. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020;395(10237):1595–8. (PMID: 10.1016/S0140-6736(20)31034-5) ; Dror AA, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–9. (PMID: 10.1007/s10654-020-00671-y) ; Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325–30. (PMID: 10.1007/s10654-020-00634-3) ; McAteer J, Yildirim I, Chahroudi A. The VACCINES act: deciphering vaccine hesitancy in the time of COVID-19. Clin Infect Dis. 2020;71(15):703–5. (PMID: 10.1093/cid/ciaa433) ; Puri N, et al. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–93. (PMID: 10.1080/21645515.2020.1780846) ; Tervonen T, Jimenez-Moreno AC, Krucien N, et al. Willingness to wait for a vaccine against COVID-19: results of a preference survey. Patient. 2020. https://doi.org/10.1007/s40271-020-00483-y . (PMID: 10.1007/s40271-020-00483-y333139917733866) ; Goldman RD, et al. Caregivers’ willingness to accept expedited vaccine research during the COVID-19 pandemic: a cross-sectional survey. Clin Ther. 2020;42(11):2124–33. (PMID: 10.1016/j.clinthera.2020.09.012) ; González-Melado FJ, Di Pietro ML. The vaccine against COVID-19 and institutional trust. Enferm Infecc Microbiol Clin. 2020. https://doi.org/10.1016/j.eimc.2020.08.001 . (PMID: 10.1016/j.eimc.2020.08.001330694937834478) ; Mahase E. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts. BMJ. 2020;371:m4042. (PMID: 10.1136/bmj.m4042) ; Ojikutu BO, Stephenson KE, Mayer KH, Emmons KM. Building trust in COVID-19 vaccines and beyond through authentic community investment. Am J Public Health. 2021;111(3):366–8. https://doi.org/10.2105/AJPH.2020.306087 . (PMID: 10.2105/AJPH.2020.306087333013527893367) ; Opel DJ, Salmon DA, Marcuse EK. Building trust to achieve confidence in COVID-19 vaccines. JAMA Netw Open. 2020;3(10):e2025672. (PMID: 10.1001/jamanetworkopen.2020.25672) ; Schwartz JL. Evaluating and deploying Covid-19 vaccines—the importance of transparency, scientific integrity, and public trust. N Engl J Med. 2020;383(18):1703–5. (PMID: 10.1056/NEJMp2026393) ; Trogen B, Oshinsky D, Caplan A. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA. 2020;323(24):2460–1. (PMID: 10.1001/jama.2020.8917) ; Warren RC, et al. Trustworthiness before trust—covid-19 vaccine trials and the black community. N Engl J Med. 2020;383(22):e121. (PMID: 10.1056/NEJMp2030033) ; Craig BM. United States COVID-19 vaccination preferences (CVP): 2020 hindsight. Patient. 2021. https://doi.org/10.1007/s40271-021-00508-0. ; Brown RCH, et al. The scientific and ethical feasibility of immunity passports. Lancet Infect Dis. 2021;21(3):e58–63. https://doi.org/10.1016/S1473-3099(20)30766-0 . (PMID: 10.1016/S1473-3099(20)30766-033075284) ; Brown RCH, et al. Passport to freedom? Immunity passports for COVID-19. J Med Ethics. 2020;46(10):652–9. (PMID: 10.1136/medethics-2020-106365) ; Kofler N, Baylis F. Ten reasons why immunity passports are a bad idea. Nature. 2020;581(7809):379–81. (PMID: 10.1038/d41586-020-01451-0) ; Persad G, Emanuel EJ. The ethics of COVID-19 immunity-based licenses (“immunity passports”). JAMA. 2020;323(22):2241–2. (PMID: 10.1001/jama.2020.8102) ; Voo TC, Clapham H, Tam CC. Ethical implementation of immunity passports during the COVID-19 pandemic. J Infect Dis. 2020;222(5):715–8. (PMID: 10.1093/infdis/jiaa352) ; Tidy J. Covid-19: vaccines and vaccine passports being sold on darknet. 2021 https://www.bbc.co.uk/news/technology-56489574 . Accessed 30 Mar 2021. ; European Commission. Coronavirus: Commission proposes a Digital Green Certificate [media release]. 2021 Mar 17. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_1181 . ; Poteet S, Craig BM. QALYs for COVID-19: a comparison of US EQ-5D-5L value sets. Patient. 2021. https://doi.org/10.1007/s40271-021-00509-z . (PMID: 10.1007/s40271-021-00509-z337828408007385) ; Donaldson C, Mitton C. Coronavirus: where has all the health economics gone? Int J Health Policy Manag. 2020;9(11):466–8. (PMID: 326108087719210) ; Eikenberry SE, et al. To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model. 2020;5:293–308. (PMID: 323559047186508) ; Lyu W, Wehby GL. Community use of face masks and COVID-19: evidence from a natural experiment of state mandates in the US. Health Aff (Millwood). 2020;39(8):1419–25. (PMID: 10.1377/hlthaff.2020.00818) ; Matuschek C, et al. Face masks: benefits and risks during the COVID-19 crisis. Eur J Med Res. 2020;25(1):32. (PMID: 10.1186/s40001-020-00430-5)
- Substance Nomenclature: 0 (COVID-19 Vaccines)
- Entry Date(s): Date Created: 20210422 Date Completed: 20210512 Latest Revision: 20210512
- Update Code: 20240513
- PubMed Central ID: PMC8060338
|
